This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Giakkoupi, P.
Right arrow Articles by Vatopoulos, A. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Giakkoupi, P.
Right arrow Articles by Vatopoulos, A. C.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, April 2008, p. 1568-1569, Vol. 46, No. 4
0095-1137/08/$08.00+0     doi:10.1128/JCM.02345-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

LETTER TO THE EDITOR

Supplementation of Growth Media with Zn2+ Facilitates Detection of VIM-2-Producing Pseudomonas aeruginosa{triangledown}


arrow
LETTER
 
Isolation rates of Pseudomonas aeruginosa producing zinc-dependent class B metallo-β-lactamases (MBLs) mainly of the VIM and IMP types are increasing worldwide (7). These enzymes exhibit wide hydrolysis spectra, including carbapenems, and are strongly inhibited by chelating agents such as EDTA. Based on the latter property, various MBL-detecting assays have been developed (1). EDTA-imipenem synergy tests are widely utilized in hospitals in Greece, where the incidence of VIM-positive P. aeruginosa is considered among the highest in Europe (www.rivm.nl/earss). However, observations in various hospitals in Athens and the reference laboratory of the National School of Public Health (NSPH) indicate suboptimal sensitivity of the EDTA-based methods. In this study, we attempted to evaluate the effect of zinc supplementation of the test medium on the performance of these methods.

Forty-three P. aeruginosa isolates submitted for testing in the NSPH from 13 hospitals during 2006 due to difficulties in interpreting the results of the EDTA-imipenem synergy methods were included in the study. MICs of β-lactams were determined by the Etest (AB Biodisk, Solna, Sweden). PCR assays for detection of MBL genes were performed as described previously (5, 6). The identities of MBL genes were confirmed by sequencing of the respective amplicons. Phenotypic detection of MBLs was performed in Mueller-Hinton agar (MHA) as well as in the same medium in which 70 mg/liter ZnSO4·7H2O had been incorporated (Zn2+ at a final concentration of 250 µM) as suggested by Lee et al. (4). Imipenem-EDTA synergy was assessed with the MBL-Etest (with a ≥8-fold decrease in the MIC of imipenem in the presence of EDTA considered a positive result) as well as two in-house techniques: the double-disk synergy test (DDST), using imipenem (10 µg) and EDTA disks (930 µg) in a 20-mm center-to-center distance, and the combination disk test (CDT), using an imipenem (10 µg) disk alone and containing 930 µg EDTA (with a ≥7-mm increase in inhibition zone considered a positive result) (3). The effects of the Zn2+ supplementation on the Etest MICs of imipenem and ceftazidime were also determined.

Twenty-seven (63%) of the 43 isolates carried blaVIM-2 (group A). The remaining 16 isolates (37%) were negative for MBL genes (group B). Imipenem MICs for group A isolates ranged from 1 to >32 µg/ml. The respective range for group B isolates was 4 to 32 µg/ml. Imipenem MICs were in good agreement with those reported by the hospital laboratories. Sensitivity problems (false negatives) were noticed with all three EDTA-based methods employed. The higher sensitivity score was observed with DDST followed by MBL-Etest and CDT. Also four of the group B isolates appeared false positive (Table 1), producing slight although reproducible synergy images. Imipenem MICs of the false-positive isolates ranged from 8 to 32 µg/ml.


View this table:
[in this window]
[in a new window]

  		TABLE 1. Properties of 43 P. aeruginosa isolates

Incorporation of Zn2+ in the growth medium resulted in a significant increase in the sensitivity of all three MBL detection methods without compromising specificity. More specifically, in Zn2+-supplemented MHA, the MBL-Etest and CDT correctly identified 27 (sensitivity 100%) and 26 (sensitivity 96%) group A isolates, respectively, while performance of the conventional testing techniques was poor. Likewise, zinc supplementation increased the number of group A isolates characterized as MBL positive by the DDST from 12 to 18, thus improving sensitivity from 44 to 67% (Table 1). A plausible explanation for the positive effect of Zn2+ on MBL detection in P. aeruginosa is that Zn2+ may facilitate formation of functional MBL molecules in the periplasmic space. Also, the relatively high Zn2+ concentrations during growth reduce expression of P. aeruginosa porins and consequently carbapenem diffusion rates (2), further enhancing the effects of carbapenemase activity. This explanation is compatible with the increase in the apparent resistance levels to imipenem and ceftazidime that was more pronounced among VIM-2 producers (Table 1).

Twenty-seven of the 43 submitted P. aeruginosa isolates (15 group A and 12 group B) were readily and correctly characterized in the NSPH by at least one conventional EDTA-based phenotypic method, likely suggesting technical problems in the hospital laboratories. Nevertheless, in a number of isolates, MBL production was not apparent. Despite the limitations of this preliminary study (a relatively small number of VIM-producing isolates), our findings suggest that Zn2+ supplementation may be a useful adjunct for MBL detection in P. aeruginosa and warrants further investigation.


arrow
ACKNOWLEDGMENTS
 
This work was partly supported by a grant from the Empirikion Foundation, Athens, Greece.


arrow
FOOTNOTES
 
{triangledown} Published ahead of print on 20 February 2008. Back


arrow
REFERENCES
 
    1
  1. Arakawa, Y., N. Shibata, K. Shibayama, H. Kurokawa, T. Yagi, H. Fujiwara, and M. Goto. 2000. Convenient test for screening metallo-β-lactamase-producing gram-negative bacteria by using thiol compounds. J. Clin. Microbiol. 38:40-43.[Abstract/Free Full Text]
    2. 2
  2. Conejo, M. C., I. Garcia, L. Martinez-Martinez, L. Picabea, and A. Pascual. 2003. Zinc eluted from siliconized latex urinary catheters decreases OprD expression, causing carbapenem resistance in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 47:2313-2315.[Abstract/Free Full Text]
    3. 3
  3. Gupta, V., P. Datta, and J. Chander. 2006. Prevalance of metallo-β-lactamase (MBL) producing Pseudomonas spp. and Acinetobacter spp. in a tertiary care hospital in India. J. Infect. 52:311-314.[CrossRef][Medline]
    4. 4
  4. Lee, K., Y. S. Lim, D. Yong, J. H. Yum, and Y. Chong. 2003. Evaluation of the Hodge test and the imipenem-EDTA double-disk synergy test for differentiating metallo-β-lactamase-producing isolates of Pseudomonas spp. and Acinetobacter spp. J. Clin. Microbiol. 41:4623-4629.[Abstract/Free Full Text]
    5. 5
  5. Poirel, L., T. Naas, D. Nicolas, L. Collet, S. Bellais, J.-D Cavallo, and P. Nordman. 2000. Characterization of VIM-2, a carbapenem-hydrolyzing metallo-β-lactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France. Antimicrob. Agents Chemother. 44:891-897.[Abstract/Free Full Text]
    6. 6
  6. Senda, K., Y. Arakawa, S. Ichiyama, K. Nakashima, H. Ito, S. Ohsuka, K. Shimokata, N. Kato, and M. Ohta. 1996. PCR detection of metallo-β-lactamase gene (blaIMP) in gram-negative rods resistant to broad-spectrum β-lactams. J. Clin. Microbiol. 34:2909-2913.[Abstract]
    7. 7
  7. Walsh, T. R., M. A. Toleman, L. Poirel, and P. Nordmann. 2005. Metallo-β-lactamases: the quiet before the storm? Clin. Microbiol. Rev. 18:306-325.[Abstract/Free Full Text]
Panagiota Giakkoupi
Sofia Vourli
Michalis Polemis
Department of Microbiology
National School of Public Health
Athens 115 21, Greece

Victoria Kalapothaki
Department of Hygiene & Epidemiology
Medical School, Athens University
Athens 11527, Greece

Leonidas S. Tzouvelekis
Department of Microbiology
Medical School, Athens University
Athens 115 27, Greece

Alkiviadis C. Vatopoulos*
Department of Microbiology
National School of Public Health
196 Alexandras Avenue
Athens 115 21, Greece

* Phone: 30.2106422278 Fax: 30.2106454002 E-mail: avatopou{at}nsph.gr

Journal of Clinical Microbiology, April 2008, p. 1568-1569, Vol. 46, No. 4
0095-1137/08/$08.00+0     doi:10.1128/JCM.02345-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.




This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Giakkoupi, P.
Right arrow Articles by Vatopoulos, A. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Giakkoupi, P.
Right arrow Articles by Vatopoulos, A. C.

Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»